statins' new safety concerns

Patients will ask about statins' new safety concerns.

About 25% of adults over 45 are on a statin. Now new labeling will warn about a higher risk of diabetes or cognitive impairment.

But don't let this stop you from prescribing statins for patients who are likely to benefit...especially heart patients. And tell patients NOT to stop their statin without talking to you first.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote